Introduction to Mutation Testing For Nsclc In 2017
Let's dive into the details surrounding Mutation Testing For Nsclc In 2017. In this segment, Benjamin Levy, MD, discusses current recommendations for genetic
Mutation Testing For Nsclc In 2017 Comprehensive Overview
Luis Raez, MD, and Ben Levy, MD, discuss the role of next-generation sequencing for patients with non–small cell Sarah Goldberg, MD, describes the role of In this segment the panelists discuss the important
Panelists Mark Socinski, MD, and Alexander Drilon, MD, discuss the use of comprehensive molecular
Summary & Highlights for Mutation Testing For Nsclc In 2017
- Geoffrey R. Oxnard, MD, and Sandip Patel, MD, describe the value of large panel genetic profiling for metastatic non–small cell ...
- Alice Shaw, MD, PhD, and Tony Mok, MD, provide insight on the role of
- The importance of
- Corey J. Langer, MD, discusses the use of
- Roy S. Herbst, MD, PhD; Bruce E. Johnson, MD; and Mark A. Socinski, MD, discuss the role of genetic
That wraps up our extensive overview of Mutation Testing For Nsclc In 2017.